glp-1 for diabetes type 2 receptor agonists are increasingly used to treat and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read GLP-1 Receptor Agonists and Research

Tesaglitazar alone had no effect on GLP-1R Gs recruitment, cAMP production, GLP-1R internalization or GLP-1R-Lamp1 colocalization (Fig

Metabolic Balance Promotes fat burning while maintaining steady energy levels

Back Blume, N, Skouv, J, Larson, L-I, et al (Nov 1995) 'Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis', Journal of Clinical Investigations , 96, 2227-35

Research shows that even partial sleep deprivation (restricting sleep to four to five hours) reduces next-day GLP-1 response to meals by a measurable margin